Author

R. Valls

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:metagenomics· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

G. O'Toole· 4 shared K. Barrack· 4 shared T. H. Hampton· 3 shared C. E. Price· 2 shared J. C. Madan· 2 shared J. Madan· 2 shared M. Coker· 2 shared A. Ramsey· 1 shared

Activity by Year

2022-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

G. O'Toole

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

An In Vitro Medium for Modeling Gut Dysbiosis Associated with Cystic Fibrosis

K. Barrack, T. H. Hampton, R. Valls, S. Surve, T. Gardner, J. Sanville, J. Madan, G. O'Toole

This paper develops a novel in vitro culture medium, CF-MiPro, that mimics the CF gut environment and alters non-CF microbiomes to resemble CF-like profiles.

bioRxiv · Aug 1, 2023Microbiology

Predicting Clinical Outcomes in Infants With Cystic Fibrosis From Stool Microbiota using Random Forest Algorithms

R. Valls, T. H. Hampton, C. E. Price, K. Barrack, G. O'Toole, M. Coker, J. C. Madan

This paper uses random forest algorithms to predict clinical outcomes in children with cystic fibrosis based on stool microbiota composition.

bioRxiv · Aug 6, 2022 · PreprintMicrobiology

Development of the Intestinal Microbiome in Cystic Fibrosis in Early Life

C. E. Price, T. H. Hampton, R. Valls, K. Barrack, G. O'Toole, J. C. Madan, M. Coker

This study tracks the development of the gut microbiome in children with cystic fibrosis from birth to age 4, finding persistent dysbiosis and early signs of inflammatory bowel disease-associated microbiota.

bioRxiv · May 27, 2022Microbiology

Intestinal Bacteroides Modulates Systemic Inflammation and the Microbial Ecology in a Mouse Model of CF: Evidence for Propionate and other Short Chain Fatty Acids Reducing Systemic Inflammatory Cytokines

C. Price, R. Valls, A. Ramsey, N. Loeven, J. Jones, K. Barrack, J. Schwartzman, D. Royce, R. A. Cramer, J. Madan, B. Ross, J. B. Bliska, G. O'Toole

This study shows that Bacteroides in CF patients reduces systemic inflammation via propionate and alters microbial ecology in a mouse model of CF.

bioRxiv · Jan 5, 2022 · PreprintMicrobiology